Upgrade to SI Premium - Free Trial

BTIG Reiterates Buy Rating on Abbott Labs (ABT)

August 22, 2024 5:40 AM
BTIG analyst Marie Thibault reiterated a Buy rating and $135.00 price target on Abbott Labs (NYSE: ABT).The analyst comments "During ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments

Next Articles